Gemcitabine/Docetaxel Treats Nonmuscle-Invasive Bladder Cancer
Authors say Gem/Doce warrants further study for the treatment of BCG-naive high-risk non-muscle-invasive bladder cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.